Back

Delayed-onset cardiotoxicity of anthracyclines is associated with dysregulation of FOXK1 targets

19 June 2026 (08:30 - 17:30)
Organised by: Logo
Congress Presentation Part of: Poster session (1) Research and New Technology CCO Premium Access ESC Cardio-Oncology 2026 Council of Cardio-Oncology

About the speaker

Photo
Mr Vighnesh Sunder

University Hospital Heidelberg, Heidelberg (Germany)

45 More presentations in this session

Presentation thumbnail
Exploring lipoprotein(a) and incident heart failure in cancer patients with anthracycline-associated neoplasms
Mrs A. Stephanus (Brasilia, BR)
Abstract Slides
Presentation thumbnail
ICARE-TNBC : Immune checkpoint-associated cardiotoxicity risk evaluation in early-stage triple-negative breast cancer
Miss L. Dib (Paris, FR)
Abstract
Presentation thumbnail
Incidence and risk profile of venous thromboembolic events in patients undergoing immune checkpoint inhibitor therapy
Doctor Z. Sandor (Budapest, HU)
Abstract Slides
Presentation thumbnail
Pericoronary fat attenuation on coronary ct identifies persistent vascular inflammation after chest radiotherapy in cancer survivors
Doctor T. De Silva (London, GB)
Abstract Slides
Presentation thumbnail
Optimizing troponin T screening for immune checkpoint inhibitor-associated myocarditis
Mr T. Uyl (Rotterdam, NL)
Abstract Slides

Access the full session

Session thumbnail
Poster session (1)

The Event

Event poster

ESC Cardio-Oncology 2026

19 June 2026 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Anthracycline exposure alters the response to future cardiac stress response driven by FOXK1
20 June 2025
thumbnail
Congress Session
Young Investigator Award (YIA) Basic Science
17 May 2025
thumbnail
Congress Presentation
Association of echocardiographic radiomics-based features with cardiotoxicity effect in breast cancer patients from the CARDIOCARE project
11 December 2024
thumbnail
Congress Presentation
Cardioprotective effects of the flavonoid quercetin against doxorubicin-Induced cardiotoxicity in H9c2 cardiomyoblasts
20 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources